Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion

This publication has 38 references indexed in Scilit:

• Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
  European Journal of Immunology, 2001
• A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4⁺Cell Counts ⩾350/mm³
  The Journal of Infectious Diseases, 2000
• Efficacy of Low‐Dose Subcutaneous Interleukin‐2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load
  The Journal of Infectious Diseases, 1999
• A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection
  The Journal of Infectious Diseases, 1999
• Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.
  Journal of Clinical Investigation, 1997
• A Phase I Study of Interferon-α2b in Combination with Interleukin-2 in Patients with Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 1994
• A Phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine
  AIDS, 1994
• Intralymphatic interleukin-2 treatment of a hemophiliac AIDS patient with defective interleukin-2 production
  Journal of Molecular Medicine, 1987
• Therapy of Acquired Immune Deficiency Syndrome with Recombinant Interleukin-2
  AIDS Research and Human Retroviruses, 1987
• Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
  Journal of Clinical Investigation, 1983